HIV-1 viral load and clinical outcome: review of recent studies

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2018

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Science (New York, N.Y.)·2014

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Advances in virology·2012

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Advances in virology·2012

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2010

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Proceedings of the National Academy of Sciences of the United States of America·2009

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

AIDS (London, England)·2026

Cancer incidence and risk factors among people with HIV in REPRIEVE.

AIDS (London, England)·2026

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

AIDS (London, England)·2026

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

AIDS (London, England)·2026

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

AIDS (London, England)·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

British journal of haematology·2026

Tat-dependent protein translocation and its evolution.

FEMS microbiology reviews·2026

Theranostics in the management of prostate cancer: from concept to clinical practice.

Expert review of clinical pharmacology·2026

miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.

Nucleosides, nucleotides & nucleic acids·2026

Th1-biased iNKT cell agonist-loaded liposomal peptide vaccines synergize with a PD-L1 inhibitor to boost immunotherapy against gastric cancer.

Chemical communications (Cambridge, England)·2026

Nanoparticle-Based Delivery Strategies for Targeted Protein Degradation.

Advanced healthcare materials·2026

Related Experiment Videos

HIV-1 viral load and clinical outcome: review of recent studies

Related Concept Videos

Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

Cancer incidence and risk factors among people with HIV in REPRIEVE.

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

Tat-dependent protein translocation and its evolution.

Theranostics in the management of prostate cancer: from concept to clinical practice.

miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.

Th1-biased iNKT cell agonist-loaded liposomal peptide vaccines synergize with a PD-L1 inhibitor to boost immunotherapy against gastric cancer.

Nanoparticle-Based Delivery Strategies for Targeted Protein Degradation.

Related Experiment Videos

HIV-1 viral load and clinical outcome: review of recent studies

Related Concept Videos

Related Articles